Advertisement
News
Advertisement

Detecting Single Cancer Molecules

Wed, 06/02/2010 - 8:38pm
Massachusetts Institute of Technology

Quanterix, a diagnostics startup in Cambridge, MA, has developed a highly sensitive new technology capable of detecting a single, cancer-linked molecule in blood, to predict the recurrence of prostate cancer. In a new study of 30 men who had their prostates removed, the test could detect low levels of the molecule that commercial assays missed.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading